172@29@17@141!~!172@29@0@53!~!|news|tags|alembic-pharma.html!~!|controller|tag.php
alembic pharma
Jump to
126 Results Found
  • Buy Alembic Pharma; target of Rs 1140: ICICI Direct Jul 24, 2020 04:41 PM IST

    Buy Alembic Pharma; target of Rs 1140: ICICI Direct

    ICICI Direct is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1140 in its research report dated July 23, 2020.

  • Buy Alembic Pharma; target of Rs 1180: YES Securities Jul 23, 2020 07:08 PM IST

    Buy Alembic Pharma; target of Rs 1180: YES Securities

    YES Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1180 in its research report dated July 22, 2020.

  • Neutral Alembic Pharma; target of Rs 1122: Motilal Oswal Jul 23, 2020 07:03 PM IST

    Neutral Alembic Pharma; target of Rs 1122: Motilal Oswal

    Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 1122 in its research report dated July 22, 2020.

  • Alembic Pharma Standalone June 2020 Net Sales at Rs 1,258.43 crore, up 40.33% Y-o-Y Jul 23, 2020 09:31 AM IST

    Alembic Pharma Standalone June 2020 Net Sales at Rs 1,258.43 crore, up 40.33% Y-o-Y

  • Alembic Pharma expects domestic biz to grow in double digits in the current fiscal Jul 12, 2020 01:21 PM IST

    Alembic Pharma expects domestic biz to grow in double digits in the current fiscal

    "We completed this transition in 2019-20 and started witnessing an uptick in performance in the last quarter of the fiscal," Alembic Pharmaceuticals Managing Directors Pranav Amin and Shaunak Amin said in a joint communication.

  • Alembic Pharma gets USFDA nod for generic Doxycycline Hyclate tablets Jul 01, 2020 03:15 PM IST

    Alembic Pharma gets USFDA nod for generic Doxycycline Hyclate tablets

    The company's product is a generic version of Almirall, LLC's Acticlate tablets in the same strengths, Alembic Pharma said in a BSE filing.

  • Buy Alembic Pharma; target of Rs 1100: YES Securities Jun 23, 2020 06:48 PM IST

    Buy Alembic Pharma; target of Rs 1100: YES Securities

    YES Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated June 15, 2020.

  • Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gel Jun 19, 2020 02:16 PM IST

    Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gel

    The approved product is a generic version of Galderma Laboratories LP's Differin gel in the same strength, it added.

  • Buy Alembic Pharma; target of Rs 1100: YES Securities May 20, 2020 04:24 PM IST

    Buy Alembic Pharma; target of Rs 1100: YES Securities

    YES Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated May 19, 2020.

  • Alembic Pharma Consolidated March 2020 Net Sales at Rs 1,206.83 crore, up 30.19% Y-o-Y Apr 28, 2020 11:33 AM IST

    Alembic Pharma Consolidated March 2020 Net Sales at Rs 1,206.83 crore, up 30.19% Y-o-Y

  • Alembic Pharma shares jump 5% after robust Q4 profit; volumes surge 250% Apr 24, 2020 10:04 AM IST

    Alembic Pharma shares jump 5% after robust Q4 profit; volumes surge 250%

    US generics business increased 84 percent to Rs 577 crore for the quarter and 53 percent to Rs 1,976 crore for FY20. Indian formulations business grew by 13 percent.

  • Alembic Pharma share price up over 3% after USFDA tentatively approves conjunctivitis-related drug Apr 20, 2020 11:38 AM IST

    Alembic Pharma share price up over 3% after USFDA tentatively approves conjunctivitis-related drug

    The company has total 120 ANDA approvals (107 final approvals and 13 tentative approvals) from USFDA.

  • Alembic Pharma gets EIR from USFDA for API facility at Karakhadi Mar 17, 2020 12:50 PM IST

    Alembic Pharma gets EIR from USFDA for API facility at Karakhadi

    "The company has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection carried out by them at our API facility at Karakhadi," the drug firm said in a filing to the BSE.

  • Alembic Pharma receives 4 observations from USFDA for Panelav facility Mar 16, 2020 11:40 AM IST

    Alembic Pharma receives 4 observations from USFDA for Panelav facility

    "The US Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals general oral solid formulation facility located at Panelav from 9-13 March, 2020," the drug firm said in a filing to the BSE.

  • Alembic Pharma share price up 2% after FDA nod for Azithromycin tablets Jan 28, 2020 10:32 AM IST

    Alembic Pharma share price up 2% after FDA nod for Azithromycin tablets

    Alembic has a total of 115 ANDA approvals (103 final approvals and 12 tentative approvals) from USFDA.

  • Alembic Pharma Standalone December 2019 Net Sales at Rs 1,052.36 crore, up 16.32% Y-o-Y Jan 24, 2020 01:45 PM IST

    Alembic Pharma Standalone December 2019 Net Sales at Rs 1,052.36 crore, up 16.32% Y-o-Y

  • Alembic Pharma Consolidated December 2019 Net Sales at Rs 1,209.13 crore, up 18.76% Y-o-Y Jan 24, 2020 01:30 PM IST

    Alembic Pharma Consolidated December 2019 Net Sales at Rs 1,209.13 crore, up 18.76% Y-o-Y

  • Alembic Pharma gets final USFDA nod for hypertension drug Jan 24, 2020 11:04 AM IST

    Alembic Pharma gets final USFDA nod for hypertension drug

    "Alembic Pharmaceuticals Ltd (Alembic) today announced it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Bosentan tablets, 62.5 mg and 125 mg," the firm said in a BSE filing.

  • Alembic Pharma gets final USFDA nod for Fenofibrate tablets Jan 23, 2020 12:07 PM IST

    Alembic Pharma gets final USFDA nod for Fenofibrate tablets

    "Alembic Pharmaceuticals Limited (Alembic)...has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Fenofibrate Tablets USP, 54 mg and 160 mg.

  • Alembic Pharma Consolidated December 2019 Net Sales at Rs 1,209.13 crore, up 18.76% Y-o-Y Jan 23, 2020 10:44 AM IST

    Alembic Pharma Consolidated December 2019 Net Sales at Rs 1,209.13 crore, up 18.76% Y-o-Y

  • Alembic Pharma Standalone December 2019 Net Sales at Rs 1,052.36 crore, up 16.32% Y-o-Y Jan 23, 2020 10:40 AM IST

    Alembic Pharma Standalone December 2019 Net Sales at Rs 1,052.36 crore, up 16.32% Y-o-Y

  • Market Headstart: Nifty likely to consolidate further; Axis Bank, L&T earnings today Jan 22, 2020 08:40 AM IST

    Market Headstart: Nifty likely to consolidate further; Axis Bank, L&T earnings today

    Trends on SGX Nifty indicate a positive opening for India, with a 68 points, or 0.56 percent, gain

  • Buy or Sell | Here's why Alembic Pharma is a contra bet Dec 27, 2019 02:17 PM IST

    Buy or Sell | Here's why Alembic Pharma is a contra bet

    Dinesh Rohira, CEO and Founder of 5nance.com has taken a contra view on Alembic Pharmaceuticals.

  • Initiating coverage: HDFC AMC and M&M among 10 stocks that could return 10-40% in 2020 Dec 12, 2019 11:02 AM IST

    Initiating coverage: HDFC AMC and M&M among 10 stocks that could return 10-40% in 2020

    We have collated a list of 10 stocks where different brokerage firms initiated their coverage in December

  • Market Headstart: Nifty50 seen opening flat; Maruti, Ashok Leyland eyed Nov 11, 2019 08:47 AM IST

    Market Headstart: Nifty50 seen opening flat; Maruti, Ashok Leyland eyed

    Trends on SGX Nifty indicate a flat opening for the broader index in India, with a seven-point loss, or 0.06 percent

Sections